CPhI South East Asia Rescheduled for July 2020
Ongoing coronavirus outbreak prompts date change to ensure safety of trade show participants.
Informa Markets, organizers of CPhI South East Asia, announced on Feb. 17, 2020 that the event-originally scheduled for March 4–6, 2020-has been rescheduled for July 1–3, 2020 at the IMPACT Centre in Bangkok, Thailand, due to concerns over the ongoing coronavirus (COVID-19) outbreak. The decision was made in consultation with local authorities and advice of the World Health Organization (WHO), Informa reported in a Feb. 17, 2020 press statement.
“CPhI South East Asia is a tremendous event for both Thailand and the Southeast Asian region as a whole, but the safety of our attendees, exhibitors, and staff is integral to everything that we do. Following an extensive consultation, and in line with the recommended safety measures, we are taking extra precautions and will now host the event in July. Please accept our apologies for any inconvenience caused by the rescheduled dates,” commented Silvia Forroova, brand director at Informa Markets in the press statement.
The July event will be held at the same venue but will move to the Challenger 2 hall. The event organizers stated they will “continue to provide updates to its attendees and exhibitors through direct communications and on its website in due course.”
“We thank our partners for their continued patience and understanding, and we remain available to help in any way we can. But more importantly, we must express our support for those affected in China, and all around the world,” added Forroova.
Safety measures for CPhI Japan
Additional safety measures were planned for CPhI Japan, scheduled for March 16–18, 2020 in Tokyo, according to a notice on the event website on Feb. 17, 2020. The measures, recommended by WHO and Japan’s Ministry of Health, Labor and Welfare, include the installation of hand-washing stations and a first-aid room, and encouraging all participants to wear masks. As of Feb. 3, 2020, the coronavirus infection was not recognized as an epidemic in Japan, the website notice reported.
Sources:
CPhI South East AsiaCPhI Japan
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.
